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Abstract
Background: Malaria in pregnancy is associated with increased risks of maternal and foetal complications.
Currently, intermittent preventive treatment (IPT) of malaria during pregnancy with sulphadoxine-pyrimethamine
(SP) is recommended by the WHO as part of a package of interventions also including insecticide-treated nets and
effective case management. However, with increasing resistance to SP, the effectiveness of SP-IPT has been
questioned. A randomized controlled trial (RCT) to investigate the relative efficacy of an alternative strategy of
intermittent screening and treatment (IST), which involves a rapid diagnostic test for malaria at scheduled ANC
visits and treatment of women only if positive, versus SP-IPT has been conducted in Ashanti region, Ghana. This
paper reports on a complementary study investigating the acceptability of the different strategies to women
enrolled in the trial.
Methods: Data were collected through twelve focus group discussions with women selected at random from the
different arms of the RCT, exploring their experiences and perceptions about antenatal care and their involvement
in the trial. Content analysis was used to identify relevant themes to structure the results.
Results: Five main themes emerged from participants’ experiences of ANC and the RCT that would influence their
acceptability of malaria prevention strategies during pregnancy: health benefits; drugs received; tests received;
other services received; and health worker attitude. Their own health and that of their baby were strong
motivations for attending ANC, and reported favourably as an outcome of being in the RCT. Women were not
always clear on the biomedical function of drugs or blood tests but generally accepted them due to strong trust
in the health staff. Home visits by staff and free ITNs as part of the trial were appreciated. Politeness and patience
of health staff was a very strong positive factor.
Conclusions: Overall, both intermittent screening and treatment and intermittent preventive treatment appeared
equally acceptable to pregnant women as strategies for the control of malaria in pregnancy. The women were
more concerned about quality of services received, in particular the polite and patient attitude of health staff, and
positive health implications for themselves and their babies than about the nature of the intervention.
Background
Plasmodium falciparum infection in pregnancy is asso-
ciated with an increased risk of maternal and foetal
complications including maternal anaemia and low birth
weight [1,2]. The WHO has recommended a package of
interventions for preventing and controlling malaria
infection in pregnancy (MiP) in endemic areas, which
includes the early diagnosis and treatment of malaria,
intermittent preventive treatment during pregnancy
(IPT) using sulphadoxine-pyrimethamine (SP) and the
use of insecticide-treated nets (ITNs) [3].
Currently, SP-IPT has been rated as having the most
favourable cost-benefit profile because of its relatively
low cost, high compliance and efficacy in reducing
maternal anaemia and low birth weight [4,5]. However,
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implementation of IPT in pregnancy in most settings is
limited by social, cultural, economic and operational
challenges despite good coverage of antenatal services
[6,7]. In addition, resistance to SP has been spreading
across sub-Saharan Africa and thus the effectiveness of
SP-IPT has been questioned [5]. There are few anti-
malarial drugs with plasma half-life comparable to that
of SP that could be used to replace SP for IPT in areas
with high SP resistance. Furthermore, there is very lim-
ited data on the efficacy and safety during pregnancy of
alternative drugs [8]. Studies have shown that rapid
diagnostic tests (RDT) have a reasonable sensitivity to
diagnose malaria in pregnancy [9-11]. Screening for
malaria using an RDT during focused antenatal care vis-
its and treating those women who are positive for
malaria with an effective combination of drugs (termed
intermittent screening and treatment (IST)) appears to
be an alternative approach to control MiP in areas with
high SP resistance. While some women with placental
malaria may be missed by the RDT screening, it can be
argued that the proportion of women with placental
malaria missed by an RDT would be minimal if all
women used an ITN, and that the risk of missed placen-
tal malaria would be offset by the reduction in women
unnecessarily exposed to anti-malarials of uncertain
safety profile.
A three-arm, partially-blinded, randomized trial was
conducted in the Ashanti Region of Ghana between
February 2007 and November 2008 to assess the efficacy
of the IST approach compared to SP-IPT. Women in
the IST groups were given either SP or artesunate-amo-
diaquine (AS-AQ) if they had a positive RDT result for
malaria and women in the comparison group received
SP-IPT and standard case management if they reported
with symptoms suggesting clinical malaria (Figure 1).
The effect of IST compared to SP-IPT on maternal
anaemia, birth weight and foetal outcomes observed in
this RCT is reported elsewhere (Tagbor et al, personal
communication).
However, it has been demonstrated that a highly effi-
cacious intervention given under strict trial conditions
rarely translates into an equally effective intervention
when implemented under programmatic conditions
[12-14]. There are many factors that have the potential
to influence the relative implementability of interven-
tions including: the complexity of the interventions [15];
the capacity of the health system and health providers
to deliver the interventions at the scale required; and
the acceptability of the interventions to providers and
users. A series of studies were undertaken to investigate
these factors and will be reported elsewhere. Here, the
perceptions and experiences of women enrolled in the
RCT are presented in order to assess the relative accept-
ability of IST and IPT to users.
Methods
The study was conducted during January and February
2009 in Ejisu-Juaben and Sekyere East districts of the
Ashanti region of Ghana. These are predominantly rural
districts, with the main occupation of the people being
Figure 1 Schematic diagram to show the allocation of women enrolled in the trial to focus group discussion groups.
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subsistence farming. Transmission of malaria is moder-
ately high [16] and occurs throughout the year with
peaks during the rains in May-October.
In the Ashanti region 97.4% of women received ANC
from a skilled provider at least once during their most
recent pregnancy [17], with the majority (69.8%) receiv-
ing care from a nurse, midwife or auxiliary midwife, and
the remainder receiving care from a doctor (27.6%). All
health facilities in the study districts already offer SP-
IPT to pregnant women following the Ministry of
Health (MoH) guidelines of three doses of SP-IPT. Preg-
nant women in their second or third trimester diag-
nosed with malaria are treated with AS-AQ. Counselling
and testing for prevention of mother to child transmis-
sion of HIV (PMTCT) is also part of core ANC services
in Ghana (HIV prevalence amongst adults aged 15-49 in
Ghana is 1.9% [18]). Eleven percent of pregnant women
in Ashanti region received HIV counselling and testing
at ANC and were informed of the results [19]. All
maternal health care, including delivery has been free
since July 2008, a policy implemented through the
National Health Insurance Scheme.
Women for the acceptability study were selected
through a combination of purposive and random sam-
pling strategies in order to ensure that experiences of
women from each of the three arms of the RCT were
represented, and that the views of those women that
had had a blood test on each ANC visit but were consis-
tently negative for malaria parasites and so never given
any anti-malarials, were summarized adequately. Only
women recruited during 2008 were included to limit the
length of recall for their experiences of the trial.
Women recruited from July 2008 onwards were only
recruited if a date of delivery was known. Women were
excluded from the sampling frame if the pregnancy was
known to have ended in miscarriage or stillbirth, or if a
child was known to have died shortly after birth. Of the
1,529 women meeting all other inclusion criteria, 43
(2.8%) were excluded because they had lost their baby.
Women were randomly allocated into groups on the
basis of their original RCT study arm or experience in
the study. In the RCT, women in the IST arms received
a rapid diagnostic blood test at each scheduled ANC
visit, drawing blood by a finger prick. Outside of the
trial, blood tests were requested by the midwife only if a
woman complained of malaria-like symptoms; she
would then be sent to the lab and a thick blood film
would be taken. The only other diagnostic blood tests
routinely carried out at ANC are for HIV, anaemia, sick-
ling and blood group; these are normally only carried
out at a woman’s first visit to the ANC.
Exploration of the women’s opinions on having
repeated finger pricks and blood tests at every visit was,
therefore, a key objective of the acceptability study.
Group A included women who received SP-IPT; Group
B involved women in the IST-SP arm with at least one
positive RDT; Group C included women in the IST-AS-
AQ arm with at least one positive RDT; and Group D
involved women in the IST-SP or IST-AS-AQ arms who
did not test positive with an RDT at any time during
their involvement in the trial (Figure 1).
Data were collected through a series of focus group dis-
cussions (FGD). Each FGD was moderated by one mem-
ber from a team of eight fieldworkers using a structured
discussion topic guide, with two fieldworkers conducting
observations of the process and taking notes of the dis-
cussion. All fieldworkers were female university gradu-
ates with experience in social science and/or public
health. In total, 12 FGDs were held, two with each of the
homogenous groups A, B, C and D; and four with hetero-
geneous groups i.e. combinations of women from the
four different groups (AB, CD, AD, BD) purposively cho-
sen to assess whether their different experiences sparked
interesting discussion, for example between those women
who received blood tests or did not, those that received
different types of anti-malarials, and those that received
blood tests with or without then receiving anti-malarials.
All FGDs were conducted in the local language (Twi)
and, with the informed consent of the participants, digi-
tally recorded. Because Twi is predominantly a spoken
language, translation and transcription into English were
undertaken concurrently and these transcriptions were
coded and analysed using NVivo version 8 [20]. A con-
tent analysis approach was used to identify themes
based around the women’s experiences of ANC and
their involvement in the project [21]. The issues in the
FGD topic guide included expectations of ANC visits,
experiences during ANC attendance, reasons for repeat
visits, and experiences with drugs and blood tests. Since
women within the groups were of mixed gravidae, the
reported differences in experience at ANC between last
and previous pregnancies were used as a starting point
to identify themes important to users of the current
strategies under investigation. These were then used in
conjunction with the FGD topic guide to further refine
relevant themes.
Ethical clearance and confidentiality
Ethical approval for this study was granted by the Com-
mittee on Human Research, Publications and Ethics,
Kwame Nkrumah University of Science and Technology,
School of Medical Sciences, Kumasi, Ghana; and by the
ethics committee of the London School of Hygiene &
Tropical Medicine. Verbal informed consent was sought
from all participants and recorded before the start of all
focus group discussions. During transcription, any
names were replaced with codes to ensure anonymity
and digital recordings were deleted once transcription
and translation were completed and quality approved.
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Results
Using the comparison of current versus previous preg-
nancies amongst multigravidae in the FGDs as a starting
point, three main themes were identified: (i) health ben-
efits as a motivating factor for attending ANC, and as a
positive experience of being in the project; (ii) services
received; and (iii) health worker attitude. For assessing
the relative acceptability of IST and IPT as strategies for
controlling malaria in pregnancy, ‘drugs received’ and
‘blood tests received’ are discussed as distinct themes
separately to the ‘services received’ theme.
Health benefits
In the discussions around expectations of ANC, health
emerged as a strong motivating factor for the women to
attend ANC. The most frequently mentioned reason for
ANC attendance was wanting to know if there were any
problems for themselves or for the baby with specific
concerns about avoiding adverse events, in particular
losing the baby.
“If you are a lady and you get pregnant, you must
ensure the baby is healthy and so we go to the ANC
expecting that if there is any problem anywhere the mid-
wives would be able to tell us and treat us.” (Woman X,
Group C1)
“Some people do not go to the ANC and lose their
babies as a result. I wanted to prevent that from hap-
pening to me. That’s why I went to the ANC - I did not
want to get any problems for myself.” (Woman D, Group
A2)
The majority of the comments about the health of the
baby related to knowing whether it was correctly posi-
tioned and what to do if it wasn’t. Regarding their own
health, some of the women who had already had other
children mentioned that they went to ANC to try and
avoid some of the problems they had experienced dur-
ing previous pregnancies such as stiffness and high
blood pressure. The primigravidae women wanted to
find out about the changes that were happening to their
bodies and to receive counselling on how to give birth
safely. A number of women were concerned about non-
specified “diseases” and wanted to find out if they had
any so that they could be treated appropriately. Another
common point of interest was in knowing the right kind
of foods to eat during pregnancy to gain strength and
energy for themselves and the baby.
Many of the multigravidae were keen to talk about the
improvements in their own health and that of their
babies that they perceived to have experienced during
their most recent compared to previous pregnancies.
Amongst this group, the vast majority felt that they
were healthier and had a smoother delivery with this
pregnancy compared to previous pregnancies. Positive
comments were also made about their babies being
strong, with one woman proudly showing the rest of the
group:
“Look my baby is less than 3 months old but see how
fat and healthy she looks. The drugs and by means of
God’s grace our babies look very healthy.” (Woman A,
Group D1)
However, these perceptions were not universal; some
women did not notice any difference and one said that
she had a more difficult pregnancy.
Drugs
All women reported receiving many different types of
medicine at each ANC visit and while some of the
women described these drugs by name, others distin-
guished the different types by colour and size. Drugs
that were commonly named by the women included
multivitamins and B-complex, blood tonic and fesolate
(iron tablets), while those who used colour as a descrip-
tor talked of the green, brown or red pills (green and
brown would normally be iron tablets, red normally
multivitamins). Some women referred to anti-malarials
by name, i.e. SP, Fansidar or artesunate-amodiaquine,
others used a description e.g. three white tablets taken
all together at the ANC (for SP), or the yellow and
white pills (for AS-AQ).
Women in three of the FGDs mentioned differences
in the drugs they had received at their ANC visits for
previous pregnancies and the most recent one. Two
women from one FGD group mentioned “three white
tablets” (SP) that they had not received before; however,
in the other two groups the discussions among the mul-
tigravidae relating to differences in drugs were about
differences in the amount and type of medicines that
could be classified as ‘routine drugs’ (as opposed to spe-
cific anti-malarials). The fact that in the majority of the
groups the multigravidae women did not mention drugs
in their discussions about differences between their
pregnancies suggests either that these women did not
identify that they had received different anti-malarial
drugs or that these differences were not as important to
them as other differences they had noticed during their
last pregnancy. For some women it may be true that
there were no differences in the anti-malarial drugs they
received, namely those in the SP-IPT arm who could
have received IPT in other recent pregnancies as routine
practice. However, most of the women did receive dif-
ferent anti-malarial drugs, or at least according to a dif-
ferent strategy, during their recent pregnancy as part of
the RCT. These findings could suggest either that the
women don’t know what the different drugs are for (and
so could not distinguish that they had been given a dif-
ferent anti-malarial, or no anti-malarial), or that they
know what the drugs are for but are not concerned
about (or don’t feel the need to discuss) the changes to
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the anti-malarial regime. From the comments made dur-
ing the discussion it seems more likely to be the latter
as most of the women seemed to have a reasonable idea
what the various drugs they were given were for. Quite
a few made specific mention of anti-malarial drugs,
either providing a description or their actual name;
when shown samples of SP and AS-AQ they recognized
them and could say they were for malaria - either treat-
ment or prevention.
“The B complex and multivites were for good health of
our babies, healthy appetite. And I believe the white ones
were anti-malarial.” (Woman A, Group AB1)
However, some women did not seem so sure about
the function of the different pills, but were nonetheless
pleased with the perceived effects. When asked what the
drugs were for, the women sometimes answered in
terms of what effects they saw, rather than the biomedi-
cal reasons for taking the drugs during pregnancy.
These responses give interesting insights into the per-
ceptions of non-traditional medicines.
“The medicine I took made me strong so I could do a
lot of things whilst pregnant” - “Could you tell which
ones made you strong?” - “No” - “Did you like the drugs
anyway?” - “Yes” (Woman E, Group A1)
“I was told the green and red drugs performed the
same function. My stool colour became dark after taking
the green tablets and it was the same after taking the
red tablets so I realized they were indeed the same in
nature” (Woman X, Group D2)
On the other hand, several side-effects and complaints
associated with taking specific drugs were reported,
either prompted or unprompted during the discussions.
There were a small number of women who reported
unpleasant experiences with AS-AQ or SP such as dizzi-
ness or weakness (AS-AQ), or vomiting (SP). However,
with one or two exceptions where the women reported
severe side-effects and refused to take the drugs again,
most women said that they would still take the drugs
due to the benefits that they associated with them:
“The yellow and white tablets [AS-AQ] almost killed
me. When I took it I became very weak and I couldn’t
do anything... Ever since I’ve become afraid of it.”
(Woman A, Group BD1)
“If you really want to get well, you don’t dwell on the
fact that the medicine is bitter because you know that it
will make you strong” (Woman A, Group AB1)
A small number of women given an anti-malarial said
that they recovered before completing the course and so
they did not continue taking the drugs, but this was not
a commonly reported occurrence.
There were also some cases where women reported
not finishing all of the routine drugs they had been
given for a variety of other reasons. For example, some
women said that the nutritional supplements had the
effect of making them feel hungry so if they didn’t have
enough money for food they did not take them. A cou-
ple of women mentioned that they did not want to take
all of the drugs because they were worried that their
baby would grow too big. This suggests some interesting
perceptions about the effect of drugs and taking drugs
during pregnancy. The women implied that by taking all
of the drugs the baby would grow to be relatively large,
and this could lead to a difficult delivery.
Despite the reported side effects and concerns, there
were more positive comments on the effects of the
drugs than negative. For example, increased appetite
was seen by most women as positive because it led to
increased food intake which resulted in more strength
and energy for carrying on with their normal jobs.
Other positive comments included that some of the
drugs helped them to sleep well and made them urinate
a lot. This was seen as advantageous as it helped to
flush out illness or impurities. Indeed, many of the
women reported that the receipt of drugs was one of
their main motivations for going to ANC and it was
their responsibility to take them for their own good:
“There are some people who refuse to take the drugs
given to them at the ANC. When they encounter any
problems, they blame the midwives forgetting that it is
their fault.” (Woman B, Group A2)
Blood tests
Amongst the multigravidae, only two women made spe-
cific comments about their most recent versus previous
ANC experience regarding tests. One commented that
the blood test and treatment for malaria parasites
(locally referred to by the abbreviation ‘MPs’) was differ-
ent to their previous pregnancy; the other observed that
they had previously had urine tests at each visit which
they did not experience as often this time. This lack of
specific comment reflects the general reaction among
the women that the blood tests were not a ‘stand-out’
part of their ANC experience. That is not to say that
they did not have opinions on the blood tests when spe-
cifically asked. Most of the women acknowledged that
the tests were painful but they were generally perceived
to be acceptable as long as they knew what the test was
for. However, while some of the women were able to be
specific and named malaria (or MPs), anaemia, or HIV
as the reason for the blood tests, many of the women
were more vague saying that the tests were for ‘diseases’.
Despite this lack of clarity on disease specificity, it was
clear that most of the women liked to know whether or
not they had any diseases so that if they did they could
be treated appropriately. Likewise, the reassurance
gained from a negative test result was important. As
with the drugs, there were some women who made it
clear that they were only agreeing to the blood tests for
the good of their baby - it seems they would otherwise
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have refused. However, when specifically questioned
about how the repeated ‘pricks’ made them feel, again
the women did not seem overly concerned.
“Even though it was painful I liked it because [I] was
investigated.” (Woman G, Group BD1)
“Had it not been for the health of my baby, I would
not have agreed to the pricking” (Woman B, Group AB1)
“Yes [it is painful], but even the delivery is more pain-
ful than the pricking” (Woman F, Group CD1)
While most of the women said they were happy to
have tests so that they could find out about any diseases
that they might have, when asked if they had been told
the results of the tests, most of the women said they
had not. However, they often followed that by saying
that they had received drugs e.g. for malaria or been
told to eat more as they didn’t have enough blood
(anaemia), or the result had been written in their mater-
nal health books. These data suggest that the ANC staff
rarely provide verbal feedback on test result but, based
on the actions taken (or on the information written on
their cards) the women are happy to make assumptions
and come to their own conclusions about the test
results.
In addition to the lack of objection to the blood tests,
which suggests indirect acceptability of the IST strategy,
a small number of women made comments which
demonstrated a more direct acceptance; namely that
they preferred to know the results of tests before being
given a drug:
“It is good because the results tell the kind of drugs to
be given. I prefer to go to the lab and be told the results
and given drugs than just given drugs without any
results. It should continue.” (Woman B, Group CD1)
Other services received
Aside from the discussions around drugs and tests
received at ANC, there were a number of comments
about other services received, some of which related
directly to being in the trial rather than the different
strategies per se. For example, free ITNs were given to
all women who enrolled in the trial and a number of
the women said they had heard about the project from
friends and reported that getting a net was one of their
motivations for attending ANC. Several of the multigra-
vidae highlighted this as an important difference
between their most recent and previous pregnancies.
They also attributed health benefits (e.g., feeling stron-
ger and having heavier babies) to having slept under an
ITN.
In addition, as part of the RCT, local community drug
distributors were recruited to follow-up the women in
their communities. Their responsibilities included: col-
lecting socio-demographic and household level data;
reminding participants of their next ANC appointment;
checking that drugs were being taken correctly; and
investigating whether or not the ITNs were being used.
These follow-up visits were frequently mentioned by the
multigravidae as being an important and positive differ-
ence to the services that that they had received during
previous pregnancies. It seems that this extra level of
attention and contact was highly appreciated, especially
by those that lived far from the health facility.
“I like the fact that I was being visited regularly. One
day I was at home when I was suddenly visited. They
treated me very nicely. I did not get that during my pre-
vious pregnancy. They even checked to see if I was sleep-
ing under my net”. (Woman C, Group D2)
Three of the multigravidae also mentioned that they
were impressed with the fact that the services provided
at the ANC clinic were free which meant that they were
able to attend more regularly. However, while some of
the multigravidae may have perceived that this was asso-
ciated with the trial, in fact following a policy change
implemented in July 2008, ANC services had been pro-
vided free to all pregnant women in Ghana via the
National Insurance Scheme. A number of the other
women also commented on being impressed with
receiving many free services. For example, other things
mentioned were ultrasound scans, which they liked
because it showed them the position of the baby and in
some cases the gender. Others reported being given
food or drink during their ANC visits while they waited
in the queue, and water being available to take the
drugs at the health facility.
Positive comments were also made about the advice
that they were given during ANC. For example, they
appreciated being told the right food to eat, the correct
way to lie to ensure the baby was in a good position,
how to deliver safely and things to do at home after the
birth.
Health worker attitudes
Many comments were made by the women about being
treated ‘warmly’ and ‘with care’ during their ANC visits,
referring to both the project staff and the midwives.
Other comments related to the ‘patience’ and ‘tolerance’
of clinic staff, and having a fun time at ANC with
prayers and singing at the start of the session. The
warm attitude of the midwives also encouraged them to
return for repeat visits, reporting that people like to go
where they are treated nicely. One of the women’s com-
ments suggested that the attitude of the health workers
was the most important aspect of their satisfaction; the
drugs and other tests were the same as a previous preg-
nancy, but the extra care and attention was something
different this time:
“I think there is a difference because [at] the previous
hospital we were only checked and given drugs, but in
this last one the nurses really took their time and con-
versed with me and told me the kind of food to eat and
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the things to do when I come home. I think this was bet-
ter”. (Woman C, Group CD1)
Not everybody had such a positive experience and
there were some reports of being shouted at. For exam-
ple, one woman reported that when they complained
about waiting a long time for their drugs the midwife
got angry and wouldn’t deal with them any further.
However, although some negative comments were made
these were actually very few, and tended to refer to
other peoples’ experiences that they had heard rather
than their own.
“Some people complained of a midwife who shouted at
them when they were delivering their babies. She did not
treat me this way, she was nice to me.” (Woman B,
Group A2)
Several comments were made at various points
throughout the discussions, which suggest that the
health workers are respected and viewed as figures of
authority and the women effectively do what they are
told. The ways in which the women talk about their
overall acceptance of whatever drugs and tests they are
given reinforces this impression and suggests that they
have a lot of trust in what the midwives are telling them
and so they follow their advice/instructions.
“I was strong throughout my pregnancy because I did
everything I was told to do.” (Woman X, Group D2)
“I did not know the reason for giving me the white
drug. But I took it.” (Woman A, Group A2)
Discussion
The themes that emerged during the discussions among
women who had experienced other pregnancies were
the same as those that emerged during the general dis-
cussions involving all of the women about IST and IPT
and their overall experience of ANC whilst participating
in the trial. That is, the health of themselves and their
babies was a key motivating factor for ANC attendance
among all groups and the services received and the atti-
tude of the health workers were important features asso-
ciated with satisfaction with those services.
In general, there was little to distinguish the percep-
tions and reported experiences among the women
enrolled in the different arms of the trial. For example,
women in the SP-IPT arm said that they had experi-
enced several blood tests and contributed to discussions
about these tests despite most likely only having had a
single blood test at their first ANC visit and thereafter
receiving SP presumptively. A number of women in the
SP-IPT arm also mentioned that they had taken AS-AQ,
and could provide comments on their experience with
this anti-malarial. However, while these women should
not have received AS-AQ as part of their involvement
in the trial, if they had complained of malaria symptoms
then they would have been tested and treated with AS-
AQ if found to be parasite positive, as per national pol-
icy; SP is reserved for preventive treatment only. For the
women involved, it may be that the underlying reasons
for tests and treatments were not entirely clear and the
overall differences in experience among the groups were
so subtle that in the discussions of their experiences it
was difficult to distinguish which group had been
involved in which arm of the trail. This would perhaps
explain why no strong differences in opinion were
observed among the different groups.
The findings of the study did not always match with
what the study team had expected to be important for
the women. For example, it was expected that women
might have objections to repeated finger pricks for
blood tests, especially if they did not always result in
any treatment.
However, the results have shown that this was not a
major issue for the majority of women; even though the
tests are painful the women said that they were pre-
pared to accept them for the sake of their health. Like-
wise, their knowing that they did not have any problems
after having the first test motivated them to have the
repeated finger pricks. This acceptance probably reflects
the trust that these women have in the midwives and
the advice that they give. Similarly, it was expected that
the participants may have had complaints about seeing
other women receiving different drugs or treatment at
the ANC; however this was rarely raised as an issue.
Where it was discussed, some of the women said that
they hadn’t seen what other women received, others
thought that they all had received the same treatment,
while others had noticed differences but said that they
didn’t mind that they had all received different things as
they believed they may all have had different ailments
bothering them or be at different stages in their
pregnancy.
These data suggest that even though the different stra-
tegies seem quite distinct to the study team, i.e. depend-
ing on which arm of the trial a woman is in she will
either have a blood test at each ANC visit or not, and
receive SP to take at the health facility or AS-AQ to
take at home or nothing, in reality these differences
become diluted by other events occurring at ANC. Such
findings seem to imply that women aren’t always aware
of the full details of what they are being given; this may
be in terms of the names and functions of all of the dif-
ferent drugs, or the reasons for and results of the blood
tests. However, even if the women could not report
what specific drugs or tests were for in a strict biomedi-
cal sense, many of them had their own rational explana-
tions. For example, some of the routine drugs ‘gave
them more blood’ or drugs that made them urinate a
lot were considered good because they flush out disease.
These results agree with the findings of the acceptability
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studies that were conducted alongside trials of intermit-
tent preventive treatment in infants (IPTi) in Tanzania
and Mozambique; mothers accepted IPTi delivered at
the same time as routine vaccinations due to a percep-
tion of both services being ‘generally beneficial’, without
necessarily being able to be provide specific details of
the interventions [22,23].
However, it may be that the acceptance of variation in
what women receive at ANC would have been different
if some had received nothing at all and others had
received something. In this setting the women are
already receiving many routine drugs so adding in dif-
ferent anti-malarials is perhaps not particularly notice-
able. However, if some women had received ITNs and
others hadn’t then comments made during the discus-
sions suggest that there would have been more
complaints.
Overall, it seems that the specific issues around the
drugs and blood tests were less important to the preg-
nant women attending ANC in this study than their
perceptions of the general health benefits and their
experiences of the quality of services received. For
example, most of the unprompted discussion revolved
around an appreciation of the advice and counselling
received from the midwives (and project staff), and the
friendliness and patience of staff. Health was a strong
motivation for attending ANC, both for themselves and
their baby. On the whole, their personal perceptions of
their last pregnancy were that the services they had
received at ANC had made them strong, and led to
smoother deliveries and heavier babies. There was no
apparent difference between women in the different
arms of the trial, suggesting that from the women’s
point of view both strategies are equally acceptable. The
findings that ANC is perceived as important for the
health of their pregnancy and that they have a strong
sense of trust in the midwives is supported by findings
from other studies [24].
Certain positive aspects reported by the women are
undoubtedly related to being involved in a trial; for
example, the free ITNs and home visits. Being involved
in a trial per se may also have a positive effect on per-
ceptions of the services received [25]. It is also possible
that the attitudes of health workers may have been bet-
ter in trial facilities due to the extra help that the project
staff provided for the midwives. However, comments on
polite and patient health workers were not universal,
indicating that not all midwives were positively influ-
enced by being involved in the project. Nonetheless,
care must be taken in interpreting the results of this
acceptability study, as the experiences of the participants
during implementation of the various strategies under
trial conditions may be noticeably different to their
experiences of implementation within the routine ANC.
The project staff was present on ANC clinic days dur-
ing the trial, conducting the RDTs and dispensing anti-
malarial drugs as appropriate according to the arm of
the trial the woman was in. However, all other activities
of the ANC sessions, such as the health education talks,
HIV counselling and testing, and urine dipstick tests,
were conducted as usual by the midwives. One of the
main differences should IST be introduced into routine
ANC as a replacement for SP-IPT would be the need
for regular RDTs to be carried out. Currently, all diag-
nostic tests for pregnant women in the facilities that
were involved in the trial are conducted by a laboratory
technician, with the exception of urine dipstick tests
that the midwives do in the ANC. In the larger health
facilities, an ANC clinic day is often arranged with ‘sta-
tions’ which the women move between after a group
health education session to receive the different services
such as weighing, blood pressure, routine drugs and SP-
IPT. IST with a RDT could be introduced into this sys-
tem with little impact on the time that the women had
to be at the clinic. In the smaller facilities with less staff,
introducing IST for the midwife to implement may
mean that women have to wait longer than if they
received SP-IPT. Thus, it is possible be that the accept-
ability of the two strategies under routine conditions
will vary according to facility size or type. However, it is
likely that in facilities with a laboratory technician, the
technician would conduct the RDTs along with other
routine laboratory assessments so there would not be a
noticeable change for the women between the two stra-
tegies since they would be sent to the laboratory any-
way, regardless of the strategy.
An increased workload for the midwives in the
absence of the study team and possible stock outs of
drugs or RDTs could impede on the perceived quality of
service received. Negative health worker attitudes
towards clients is a common theme in qualitative studies
of experiences of health care in sub-Saharan Africa
[24,26], and it is possible that the presence of the trial
team resulted in changes to health worker practice that
might not be maintained in non-trial conditions. In
addition, as was found in this study, the perceived qual-
ity of ANC services is a strong motivator (or barrier) to
attendance in a variety of settings [24,27,28]. Thus,
maintaining positive health worker attitudes and the
availability of high quality services under routine condi-
tions remains a challenge, requiring on-going supervi-
sion and improvement and these factors will be critical
to the success of any maternal health intervention. The
cost of ANC is another commonly reported barrier to
ANC attendance and the lack of fees for the services
received by women in this trial was considered as
another positive aspect of their ANC experience. All
maternal health services are now free in Ghana via the
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National Health Insurance Scheme, with indications that
this is increasing ANC attendance [29]. Provided the
scheme continues, this is likely to be a facilitating factor
to the success of future maternal health interventions.
In addition to being participants in a trial, it is also
important to highlight the fact that the women who
attended the FGDs may be different to those that didn’t;
even though there was some element of randomization
to the selection process, not all of those selected then
turned up. Similarly, women were excluded whose
babies did not survive the pregnancy, women who may
have expressed more negative views of the trial. How-
ever, the aim of FGDs is to build a picture of the range
of opinions on the topic under investigation. In this
instance, after conducting 12 FGDs ‘saturation’ was
reached with similar perceptions, views and experiences
being expressed across the groups and no new informa-
tion being provided. While these data are not, therefore,
generalized to all of the trial participants, they do pro-
vide an insight into the issues that many of the women
themselves perceived to be of importance in their
experiences of the ANC services and malaria prevention
strategies received during the trial.
The current treatment regimen for AS-AQ is two
tablets of artesunate and two tablets of amodiaquine in
the morning and evening for three days. This is consid-
erably more complex than the treatment or prevention
regimen for SP which involves a single dose of two or
three tablets and can thus be taken as directly observed
therapy (DOT), as recommended for SP-IPT. This has
implications for adherence to IST-AS-AQ. However, the
little evidence available in the published literature on
adherence to AS-AQ suggests that this barrier can be
overcome through appropriate information given by
providers [30-32]. During an RCT of alternative anti-
malarials for the treatment of malaria in pregnancy,
Tagbor et al [30] found that despite a high prevalence
of minor adverse events, 96% of women completed the
3-day course of AQ or AQ-SP combination. Such find-
ings are supported by this study; a small number of
women given AS-AQ said that they recovered before
completing the course and so they did not continue tak-
ing the drugs, but this was not a commonly reported
occurrence. Nevertheless, adherence to AS-AQ will need
to be monitored as a potential operational barrier if the
IST strategy is implemented on a large-scale [33].
In addition to understanding the acceptability of the
strategies from a user perspective, it is also necessary to
understand the provider perspective, including implica-
tions for implementation. A more detailed analysis of
provider experiences and preferences of IST and IPT
will be reported elsewhere, along with an exploration of
factors contributing to implementability under routine
(non-trial) conditions.
Conclusion
Overall, both intermittent screening and treatment and
intermittent preventive treatment seem to be equally
acceptable to pregnant women as strategies for the con-
trol of malaria in pregnancy in this setting. In contrast
to the trial team’s perspective of differences between the
two strategies that may influence the acceptability,
including frequency of blood tests and receiving differ-
ent drugs, the women were more concerned with the
quality of services received, in particular the polite and
patient attitude of health staff, and the positive health
implications for themselves and their babies.
Although these are findings from experiences in a
controlled trial setting, the study provides an insight
into the potential motivating factors and barriers to deli-
vering IST or IPT under routine ANC conditions.
Encouragement of respectful communication between
midwives and their clients can help to reinforce the
trust relationship that exists. Good quality services at
ANC are necessary to promote high coverage and to
achieve actual and perceived health benefits for mothers
and their children.
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